Hallmarks of the aging T-cell system
- PMID: 33590946
- PMCID: PMC8364928
- DOI: 10.1111/febs.15770
Hallmarks of the aging T-cell system
Abstract
The adaptive immune system has the enormous challenge to protect the host through the generation and differentiation of pathogen-specific short-lived effector T cells while in parallel developing long-lived memory cells to control future encounters with the same pathogen. A complex regulatory network is needed to preserve a population of naïve cells over lifetime that exhibit sufficient diversity of antigen receptors to respond to new antigens, while also sustaining immune memory. In parallel, cells need to maintain their proliferative potential and the plasticity to differentiate into different functional lineages. Initial signs of waning immune competence emerge after 50 years of age, with increasing clinical relevance in the 7th-10th decade of life. Morbidity and mortality from infections increase, as drastically exemplified by the current COVID-19 pandemic. Many vaccines, such as for the influenza virus, are poorly effective to generate protective immunity in older individuals. Age-associated changes occur at the level of the T-cell population as well as the functionality of its cellular constituents. The system highly relies on the self-renewal of naïve and memory T cells, which is robust but eventually fails. Genetic and epigenetic modifications contribute to functional differences in responsiveness and differentiation potential. To some extent, these changes arise from defective maintenance; to some, they represent successful, but not universally beneficial adaptations to the aging host. Interventions that can compensate for the age-related defects and improve immune responses in older adults are increasingly within reach.
Keywords: T-cell aging; T-cell differentiation; T-cell homeostasis; adaptive immunity; cellular senescence; immunosenescence.
© 2021 Federation of European Biochemical Societies.
Conflict of interest statement
Conflict of Interest Statement
The authors declare no conflict of interest.
Figures
References
-
- Mallapaty S. (2020) The coronavirus is most deadly if you are older and male - new data reveal the risks. Nature 585, 16–17 - PubMed
-
- Seasonal Influenza Vaccine Effectiveness, 2017-2018. | CDC.
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI129191/AI/NIAID NIH HHS/United States
- R01 HL117913/NH/NIH HHS/United States
- R01 AI108891/NH/NIH HHS/United States
- P01 HL129941/NH/NIH HHS/United States
- R01 HL142068/NH/NIH HHS/United States
- R01 AI108906/AI/NIAID NIH HHS/United States
- R01 AI129191/NH/NIH HHS/United States
- R01 AG045779/NH/NIH HHS/United States
- R01 AI108891/AI/NIAID NIH HHS/United States
- R01 AR042527/NH/NIH HHS/United States
- P01 HL129941/HL/NHLBI NIH HHS/United States
- U19 AI057266/NH/NIH HHS/United States
- R01 HL142068/HL/NHLBI NIH HHS/United States
- U19 AI057266/AI/NIAID NIH HHS/United States
- R01 AR042527/AR/NIAMS NIH HHS/United States
- R01 AI108906/NH/NIH HHS/United States
- R01 AG045779/AG/NIA NIH HHS/United States
- R01 HL117913/HL/NHLBI NIH HHS/United States
- R01 AR042527/NH/NIH HHS/United States
- R01 HL117913/NH/NIH HHS/United States
- R01 AI108906/NH/NIH HHS/United States
- R01 HL142068/NH/NIH HHS/United States
- P01 HL129941/NH/NIH HHS/United States
- R01 AI108891/NH/NIH HHS/United States
- R01 AG045779/NH/NIH HHS/United States
- U19 AI057266/NH/NIH HHS/United States
- R01 AI129191/NH/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
